Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q3 2025 Earnings

13AugConfirmed

Q1 2025

Q2 2025

Q3 2025

-7.34

-5.04

-2.75

-0.46

Details

Expected EPS

-0.46

Actual EPS

-0.61

Surprise EPS

-0.15

Surprise Percent

+32.61%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -0.61 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.